Description

Dual-Pathway Metabolic Research

Tirzepatide is an investigational peptide developed to activate both GIP and GLP-1 receptor pathways, making it one of the first dual incretin receptor agonists studied in modern metabolic science. Its unique mechanism has established it as an important compound for laboratories investigating metabolic regulation, energy balance, and body composition.

Researchers continue to investigate Tirzepatide for its potential role in:

✔ Metabolic signaling and endocrine research
✔ Dual incretin pathway investigations
✔ Energy regulation and metabolic function studies
✔ Body composition and healthy aging research

Every Riptide Wellness Labs vial is produced to rigorous quality standards and intended exclusively for laboratory research.

Research Use Only.
Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.